PyInvesting

Market research

ALPA.NSE Alpa Laboratories Limited

NSE INR Healthcare

Latest close

57.41 —

As of Nov 11, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
1B
P/E ratio
33.68
Analyst target
Not available
Dividend yield
Not available
Beta
0.98

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Alpa Laboratories Limited is currently in a long term uptrend where the price is trading 14.4% above its 200 day moving average.

From a valuation standpoint, the stock is 85.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.

Alpa Laboratories Limited's total revenue rose by 37.5% to $332M since the same quarter in the previous year.

Its net income has increased by 44.6% to $37M since the same quarter in the previous year.

Based on the above factors, Alpa Laboratories Limited gets an overall score of 4/5.